Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

71.22USD
1 Aug 2013
Price Change (% chg)

$0.76 (+1.08%)
Prev Close
$70.46
Open
$70.65
Day's High
$71.43
Day's Low
$70.01
Volume
246,853
Avg. Vol
406,993
52-wk High
$71.43
52-wk Low
$50.96

SYK.N

Chart for SYK.N

About

Stryker Corporation (Stryker) is a medical technology company. Stryker offers a diverse array of medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. The Company operates in three business segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Its products... (more)

Overall

Beta: 0.97
Market Cap (Mil.): $26,643.19
Shares Outstanding (Mil.): 378.13
Dividend: 0.26
Yield (%): 1.50

Financials

  SYK.N Industry Sector
P/E (TTM): 23.63 27.50 37.76
EPS (TTM): 2.98 -- --
ROI: 9.83 9.26 18.76
ROE: 13.77 12.54 19.59
Search Stocks

Stryker quarterly profit falls short of Wall Street estimates

- U.S. orthopedic implant maker Stryker Corp on Thursday reported net profit fell 35 percent in the second quarter, but said adjusted earnings rose about 1 percent as sales of its hip, knee and spine products improved.

18 Jul 2013

UPDATE 1-Stryker quarterly profit falls short of Wall Street estimates

July 18 - U.S. orthopedic implant maker Stryker Corp on Thursday reported net profit fell 35 percent in the second quarter, but said adjusted earnings rose about 1 percent as sales of its hip, knee and spine products improved.

18 Jul 2013

UPDATE 1-Stryker names Dentsply executive as chief financial officer

April 8 - Medical products maker Stryker Corp on Monday named William Jellison as chief financial officer, replacing Dean Bergy, who was interim CFO.

08 Apr 2013

Stryker names new chief financial officer

April 8 - Medical products maker Stryker Corp on Monday said it named William Jellison chief financial officer, replacing Dean Bergy, who was serving as interim CFO.

08 Apr 2013

FDA warns Stryker on quality issues, marketing practices

- Orthopedic implant maker Stryker Corp said it received a warning letter from the U.S. Food and Drug Administration related to quality concerns at its Portage, Michigan facility.

12 Mar 2013

UPDATE 1-FDA warns Stryker on quality issues, marketing practices

March 12 - Orthopedic implant maker Stryker Corp said it received a warning letter from the U.S. Food and Drug Administration related to quality concerns at its Portage, Michigan facility.

12 Mar 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$58.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: Stock Traders Daily
$495.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks